Endothelial Cell News Volume 5.33 | Sept 21 2020

    0
    36







    ENDO 5.33 | Sept 21


    Endothelial Cell News by STEMCELL Technologies
    Vol. 5.33 – 21 September, 2020
    TOP STORY

    Single-Cell
    RNA-seq Unveils Unique Transcriptomic Signatures of Organ-Specific Endothelial Cells

    To investigate the transcriptomic basis of endothelial cell (EC) specificity, researchers analyzed single-cell RNA-sequencing data from tissue-specific mouse ECs generated by the Tabula Muris consortium.
    [Circulation]

    Abstract


    CloneR for Enhancing the Cloning Efficiency and Single-Cell Survival of hPSCs
    PUBLICATIONSRanked by the impact factor of the journal

    3D Curvature-Instructed Endothelial Flow Response and Tissue Vascularization

    Scientists showed proof-of-principle modeling of tumor progression and engineered cardiac tissue vascularization. They demonstrated that 3D curvature induced rotation and mixing under laminar flow, leading to unique phenotypic and transcriptional changes in endothelial cells.
    [Science Advances]

    Abstract

    Hypoxia-Mediated
    Regulation of Histone Demethylases Affects Angiogenesis-Associated Functions in Endothelial Cells

    Previous studies have demonstrated that the expression of several lysine-specific demethylases is induced by hypoxia. The authors investigated the exact mechanisms underlying this regulation and its functional implications for endothelial cell function, such as angiogenesis.
    [Arteriosclerosis Thrombosis and Vascular Biology]

    Abstract

    Synthetic
    Fluorinated L-Fucose Analogs Inhibit Proliferation of Cancer Cells and Primary Endothelial Cells

    Researchers describe the design and synthesis of a panel of fluorinated L-fucose analogs bearing fluorine atoms at the C2 and/or C6 positions of L-fucose as metabolic fucosylation inhibitors. Preliminary study of their effects on cell proliferation revealed that the 6,6-difluoro-L-fucose and 6,6,6-trifluoro-L-fucose showed significant inhibitory activity against proliferation of human colon cancer cells and human umbilical vein endothelial cells.
    [ACS Chemical Biology]

    Abstract

    Study of Sr–Ca–Si-Based Scaffolds for Bone Regeneration in Osteoporotic Models

    Investigators attempted to enlarge the application range of mesenchymal stem cells with Sr incorporation in an osteoporotic bone regeneration model to evaluate whether Sr could assist in regeneration outcomes.
    [International Journal of Oral Science]

    Full Article

    NF-κB
    Inhibition Prevents Acute Shear Stress-Induced Inflammation in the Saphenous Vein Graft Endothelium

    The authors tested the hypothesis that acute exposure of venous endothelial cells to high shear stress is associated with inflammatory responses that are regulated by NF-κB both in vitro and ex vivo.
    [Scientific Reports]

    Full Article

    New
    Perspectives of S-Adenosylmethionine (SAMe) Applications to Attenuate Fatty Acid-Induced Steatosis and Oxidative Stress in Hepatic and Endothelial Cells

    Scientists aimed to clarify the direct effects of SAMe on fatty acid-induced steatosis and oxidative stress in hepatic and endothelial cells.
    [Molecules]

    Full Article

    Atorvastatin
    Improves the Cell Proliferation and Migration in Endothelial Progenitor Cells via miR-221/VEGFA Axis

    Researchers successfully identified isolated endothelial progenitor cells from the peripheral blood of patients with coronary slow flow.
    [Bioscience Reports]

    Abstract


    Activate, expand, and differentiate your cells with cytokines, chemokines, and growth factors from STEMCELL Technologies.
    REVIEWS

    NLRP3 Inflammasome in Endothelial Dysfunction

    The authors provide a comprehensive perspective on the pivotal role of NLR-family pyrin domain-containing protein 3 (NLRP3) inflammasome activation in aggravating oxidative stress and endothelial dysfunction and the possible underlying mechanisms.
    [Cell Death & Disease]

    Full Article

    INDUSTRY AND POLICY NEWS

    Aerpio
    Announces Enrollment Completed in the 28-Day Phase II Razuprotafib Glaucoma Trial

    Aerpio Pharmaceuticals, Inc. announced that it has completed patient enrollment in its double-blind, placebo-controlled Phase II trial in patients with elevated intraocular pressure associated with open angle glaucoma or ocular hypertension.
    [Aerpio Pharmaceuticals, Inc.]

    Press Release

    Roche
    Receives Positive CHMP Opinion for Tecentriq in Combination with Avastin for the Treatment of People with the Most Common form of Liver Cancer

    Roche have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Tecentriq® in combination with Avastin® for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have not received prior systemic therapy.
    [Roche]

    Press Release

    FEATURED EVENT

    10
    Million Reasons to Defeat Cancer 2020 – Abbott World Summit

    October 13 – October 14
    Virtual


    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral
    / PhD Student – Placental Vascular Immune Response

    Purdue University – West Lafayette, Indiana, United States


    Postdoctoral Associate – Endovascular Research

    Miller School of Medicine – Miami, Florida, United States

    Postdoctoral Fellowship – Clinical Research in Autonomic Dysfunctions

    The University of British Columbia – Vancouver, British Columbia, Canada

    Intern
    – Regenerative Medicine in Pulmonary Hypertension

    United Therapeutics – Silver Spring, Maryland, United States

    Project Scientist – Cardiovascular Research

    University of California, Davis – Davis, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Endothelial Cell News
    Archives Contact Us
    Endothelial Cell News Twitter